Directorate for Pharmaceutical Affairs

Happy World Pharmacist Day!
This year’s theme — “Think Health, Think Pharmacist” — reminds us of the vital role pharmacists play in every step of the healthcare journey.
Thank you for being the trusted link between science and care. 💊💙

Happy World Pharmacists Day to all colleagues offering their pharmaceutical services across various entities!

It is being brought to your attention that new doses of aripiprazole, olanzapine, regadenoson, buprenorphine and paracetamol are now available on the Government Formulary List. More information is available here: https://pharmaceuticalaffairs.gov.mt/en/resources/circulars-and-memos/

Good Morning! Our website has a new look! The formularies, protocols and circulars can now be found under 'Resources'. The website can be accessed via this link: https://pharmaceuticalaffairs.gov.mt/

Good Afternoon! It is being brought to your attention that aripiprazole 5mg tablets, olanzapine 2.5mg tablets, and olanzapine 210mg and 300mg prolonged release injections are now available on the Government Formulary List. More information is available here: https://healthservices.gov.mt/en/pharmaceutical/Pages/Circulars.aspx

Good Morning! As part of the Government’s commitment towards increasing access to medicines, it is being brought to your attention that pirfenidone 267mg tablets are now available on the Government Formulary List. More information is available here:

Circulars and Memos

Good morning! As part of the Government’s commitment towards increasing access to medicines, it is being brought to your attention that yttrium-90 resin microspheres in vials are now available on the
Government Formulary List. More information is available here: https://healthservices.gov.mt/en/pharmaceutical/Pages/Circulars.aspx

On Wednesday 22 November 2023, a half-day stakeholder event focusing on the implementation of the European Union's Health Technology Assessment (HTA) Regulation was organised by the European Commission’s Directorate General for Health and Food Safety and the Heads of HTA Agencies Group (HAG), together with national HTA agencies.

The event has brought together key stakeholders from Spain, Italy, Malta and Portugal, including national HTA administrators and representatives from national stakeholders such as patient associations, health professionals, scientific societies, industry representatives, national decision-makers and regional health authorities.

At the event in Seville, the European Commission provided an overview of the new EU HTA Regulation. This was followed by panel discussions, featuring local speakers who will discuss key topics related to the implementation of the regulation. The event was held in English and online interpretation provided in Italian, Spanish and Portuguese.

The panels has covered the following topics:
• Understanding key elements of the EU HTA Regulation
• Challenges and opportunities in the implementation process
• Involving stakeholders in EU HTA implementation
• The panel discussion also included time for Q&A and audience participation, with the opportunity to engage in lively and constructive discussions..

The Directorate for Pharmaceutical Affairs has participated both in the event and also in the panel discussion. National stakeholders representing the Ministry for Health, health care professionals, patients and industry attended either onsite or online to this event.

This event is part of a series of regional information events to be organised in 2023 and 2024 across the EU by the European Commission’s Directorate General for Health and Food Safety and the Heads of HTA Agencies Group (HAG), together with national HTA agencies. For further information: https://health.ec.europa.eu/events/theory-practice-implementing-eu-health-technology-assessment-regulation-2023-11-22_en .

Good Morning! It is being brought to your attention that there has been a change in brand from Norditropin® prefilled pen
10mg/1.5ml to Omnitrope® solution for injection in cartridge 10mg/1.5ml. More information is available here:

Circulars and Memos

Good Morning! As part of the Government’s commitment towards increasing medicines access, it is being brought to your attention that fluoxetine 20mg/5mL oral solution is now available on the Government Formulary List. More information is available here:

Circulars and Memos